Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Enlyte Completes Acquisition of PartsTrader
Enlyte, a leader in technology, networks and services for the property and casualty industry, announced today it has completed its acquisition of PartsTrader, a leading parts procurement marketplace for auto insurers and collision repairers.
ACRD 2026 Annual Conference
Enlyte experts explore how the Ticket to Work program empowers SSDI/SSI beneficiaries to achieve financial independence while preserving benefits, showcasing our attorney-led disability services approach.
Enlyte to Exhibit at the 2026 NCIGF Annual Conference
Enlyte to Exhibit at the 2026 NCIGF Annual Conference
2026 AASCIF Annual Conference
Enlyte to Sponsor 2025 AASCIF Annual Conference in Albuquerque
IAIABC 112th Convention
The International Association of Industrial Accident Boards and Commissions (IAIABC) is an association of workers' compensation jurisdictional regu
IAIABC Forum 2026
At The Forum, the IAIABC's committees and councils discuss policy and administrat